Free Trial
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free SIGA Stock Alerts

Siga Technologies (SIGA) Competitors

Siga Technologies logo
$3.10 +0.02 (+0.65%)
Closing price 10/14/2026 04:00 PM Eastern
Extended Trading
$3.09 -0.01 (-0.19%)
As of 10/14/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SIGA vs. ANRO, SPTX, TBPH, HELP, and SGP

Should you buy Siga Technologies stock or one of its competitors? Siga Technologies's main competitors and comparable companies include Alto Neuroscience (ANRO), Seaport Therapeutics (SPTX), Theravance Biopharma (TBPH), Cybin (HELP), and Spyglass Pharma (SGP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Siga Technologies compare to Alto Neuroscience?

Siga Technologies (NASDAQ:SIGA) and Alto Neuroscience (NYSE:ANRO) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Siga Technologies has higher revenue and earnings than Alto Neuroscience. Siga Technologies is trading at a lower price-to-earnings ratio than Alto Neuroscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siga Technologies$94.57M2.36$23.28M-$0.05N/A
Alto NeuroscienceN/AN/A-$63.24M-$2.42N/A

Alto Neuroscience has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Siga Technologies' return on equity of -1.55% beat Alto Neuroscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Siga Technologies-5.19% -1.55% -1.32%
Alto Neuroscience N/A -46.46%-39.09%

55.4% of Siga Technologies shares are owned by institutional investors. 2.7% of Siga Technologies shares are owned by company insiders. Comparatively, 11.3% of Alto Neuroscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Alto Neuroscience had 1 more articles in the media than Siga Technologies. MarketBeat recorded 2 mentions for Alto Neuroscience and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.82 beat Alto Neuroscience's score of 1.05 indicating that Siga Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Siga Technologies Very Positive
Alto Neuroscience Positive

Siga Technologies has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market. Comparatively, Alto Neuroscience has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market.

Alto Neuroscience has a consensus target price of $37.25, indicating a potential upside of 71.69%. Given Alto Neuroscience's stronger consensus rating and higher probable upside, analysts plainly believe Alto Neuroscience is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Alto Neuroscience
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64

Summary

Siga Technologies and Alto Neuroscience tied by winning 7 of the 14 factors compared between the two stocks.

How does Siga Technologies compare to Seaport Therapeutics?

Seaport Therapeutics (NASDAQ:SPTX) and Siga Technologies (NASDAQ:SIGA) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

In the previous week, Seaport Therapeutics had 11 more articles in the media than Siga Technologies. MarketBeat recorded 12 mentions for Seaport Therapeutics and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.82 beat Seaport Therapeutics' score of 0.11 indicating that Siga Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Seaport Therapeutics Neutral
Siga Technologies Very Positive

55.4% of Siga Technologies shares are held by institutional investors. 2.7% of Siga Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Siga Technologies has higher revenue and earnings than Seaport Therapeutics. Siga Technologies is trading at a lower price-to-earnings ratio than Seaport Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Seaport TherapeuticsN/AN/A-$74.88M-$12.12N/A
Siga Technologies$94.57M2.36$23.28M-$0.05N/A

Seaport Therapeutics presently has a consensus target price of $37.25, indicating a potential upside of 123.32%. Given Seaport Therapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe Seaport Therapeutics is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Seaport Therapeutics
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.69
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Seaport Therapeutics has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Seaport Therapeutics' return on equity of 0.00% beat Siga Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Seaport TherapeuticsN/A N/A N/A
Siga Technologies -5.19%-1.55%-1.32%

Summary

Seaport Therapeutics beats Siga Technologies on 8 of the 14 factors compared between the two stocks.

How does Siga Technologies compare to Theravance Biopharma?

Theravance Biopharma (NASDAQ:TBPH) and Siga Technologies (NASDAQ:SIGA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

Theravance Biopharma has a net margin of 51.58% compared to Siga Technologies' net margin of -5.19%. Theravance Biopharma's return on equity of -0.77% beat Siga Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Theravance Biopharma51.58% -0.77% -0.46%
Siga Technologies -5.19%-1.55%-1.32%

99.1% of Theravance Biopharma shares are held by institutional investors. Comparatively, 55.4% of Siga Technologies shares are held by institutional investors. 7.7% of Theravance Biopharma shares are held by insiders. Comparatively, 2.7% of Siga Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Theravance Biopharma has a beta of 0.25, suggesting that its share price is 75% less volatile than the broader market. Comparatively, Siga Technologies has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market.

Theravance Biopharma presently has a consensus target price of $19.40, suggesting a potential upside of 13.92%. Given Theravance Biopharma's stronger consensus rating and higher probable upside, equities analysts clearly believe Theravance Biopharma is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Theravance Biopharma
0 Sell rating(s)
8 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Theravance Biopharma has higher revenue and earnings than Siga Technologies. Siga Technologies is trading at a lower price-to-earnings ratio than Theravance Biopharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Theravance Biopharma$104.31M8.48$105.89M$1.0116.86
Siga Technologies$94.57M2.36$23.28M-$0.05N/A

In the previous week, Siga Technologies had 1 more articles in the media than Theravance Biopharma. MarketBeat recorded 1 mentions for Siga Technologies and 0 mentions for Theravance Biopharma. Siga Technologies' average media sentiment score of 1.82 beat Theravance Biopharma's score of 0.00 indicating that Siga Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Theravance Biopharma Neutral
Siga Technologies Very Positive

Summary

Theravance Biopharma beats Siga Technologies on 12 of the 15 factors compared between the two stocks.

How does Siga Technologies compare to Cybin?

Siga Technologies (NASDAQ:SIGA) and Cybin (NASDAQ:HELP) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

Siga Technologies has higher revenue and earnings than Cybin. Siga Technologies is trading at a lower price-to-earnings ratio than Cybin, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siga Technologies$94.57M2.36$23.28M-$0.05N/A
CybinN/AN/A-$148M-$3.02N/A

Cybin has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Siga Technologies' return on equity of -1.55% beat Cybin's return on equity.

Company Net Margins Return on Equity Return on Assets
Siga Technologies-5.19% -1.55% -1.32%
Cybin N/A -71.78%-64.81%

Cybin has a consensus target price of $46.33, suggesting a potential upside of 346.37%. Given Cybin's stronger consensus rating and higher probable upside, analysts plainly believe Cybin is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cybin
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

55.4% of Siga Technologies shares are held by institutional investors. Comparatively, 17.9% of Cybin shares are held by institutional investors. 2.7% of Siga Technologies shares are held by company insiders. Comparatively, 15.0% of Cybin shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Siga Technologies has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market. Comparatively, Cybin has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market.

In the previous week, Cybin had 6 more articles in the media than Siga Technologies. MarketBeat recorded 7 mentions for Cybin and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.82 beat Cybin's score of 0.84 indicating that Siga Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Siga Technologies Very Positive
Cybin Positive

Summary

Siga Technologies beats Cybin on 8 of the 14 factors compared between the two stocks.

How does Siga Technologies compare to Spyglass Pharma?

Siga Technologies (NASDAQ:SIGA) and Spyglass Pharma (NASDAQ:SGP) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Spyglass Pharma has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Siga Technologies' return on equity of -1.55% beat Spyglass Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Siga Technologies-5.19% -1.55% -1.32%
Spyglass Pharma N/A -62.40%-24.83%

Siga Technologies has higher revenue and earnings than Spyglass Pharma. Siga Technologies is trading at a lower price-to-earnings ratio than Spyglass Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siga Technologies$94.57M2.36$23.28M-$0.05N/A
Spyglass PharmaN/AN/A-$39.87M-$7.00N/A

Spyglass Pharma has a consensus price target of $44.00, suggesting a potential upside of 85.73%. Given Spyglass Pharma's stronger consensus rating and higher possible upside, analysts plainly believe Spyglass Pharma is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Spyglass Pharma
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

55.4% of Siga Technologies shares are held by institutional investors. 2.7% of Siga Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Spyglass Pharma had 1 more articles in the media than Siga Technologies. MarketBeat recorded 2 mentions for Spyglass Pharma and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.82 beat Spyglass Pharma's score of 1.46 indicating that Siga Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Siga Technologies Very Positive
Spyglass Pharma Positive

Summary

Siga Technologies beats Spyglass Pharma on 8 of the 13 factors compared between the two stocks.

Get Siga Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SIGA vs. The Competition

Export
MetricSiga TechnologiesPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market Cap$221.30M$12.14B$7.19B$13.18B
Dividend YieldN/A2.63%2.52%19.60%
P/E Ratio-62.00655.20208.5319.36
Price / Sales2.36749.06557.5674.68
Price / Cash9.2584.0876.6852.75
Price / Book1.129.1510.515.92
Net Income$23.28M$2.82B$3.50B$380.90M
7 Day Performance-5.49%-3.79%-3.49%-3.85%
1 Month Performance4.03%-7.63%-7.76%-6.37%
1 Year Performance-63.18%-6.12%0.82%-6.01%

Siga Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SIGA
Siga Technologies
0.3523 of 5 stars		$3.10
+0.6%		N/A-62.1%$221.30M$94.57MN/A49
ANRO
Alto Neuroscience
2.2931 of 5 stars		$23.74
-1.1%		$37.25
+56.9%		+286.7%$931.45MN/AN/A68
SPTX
Seaport Therapeutics
2.7618 of 5 stars		$17.37
-6.1%		$38.57
+122.1%		N/A$929.82MN/AN/A58
TBPH
Theravance Biopharma
1.6785 of 5 stars		$17.03
flat		$19.40
+13.9%		N/A$884.18M$104.31M16.86110
HELP
Cybin
4.1465 of 5 stars		$10.76
-5.8%		$46.33
+330.6%		N/A$847.67MN/AN/A100

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SIGA) was last updated on 10/15/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
100% overnight gains?
Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...
The Oxford Club | Sponsoredtc pixel